Compare SILO & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SILO | UPXI |
|---|---|---|
| Founded | 2010 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0M | 151.0M |
| IPO Year | N/A | 2021 |
| Metric | SILO | UPXI |
|---|---|---|
| Price | $0.43 | $2.31 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 132.6K | ★ 4.5M |
| Earning Date | 11-13-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.85 |
| Revenue | $72,102.00 | ★ $20,694,575.00 |
| Revenue This Year | $1.86 | $145.75 |
| Revenue Next Year | N/A | $12.88 |
| P/E Ratio | ★ N/A | $1.22 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.36 | $1.90 |
| 52 Week High | $3.37 | $22.57 |
| Indicator | SILO | UPXI |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | 31.55 |
| Support Level | $0.42 | $2.29 |
| Resistance Level | $0.46 | $3.00 |
| Average True Range (ATR) | 0.03 | 0.24 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 50.52 | 5.37 |
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.